Population red blood cell folate concentrations for prevention of neural tube defects: bayesian model
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To determine an optimal population red blood cell (RBC) folate concentration for the prevention of neural tube birth defects. DESIGN: Bayesian model. SETTING: Data from two population based studies in China. PARTICIPANTS: 247,831 participants in a prospective community intervention project in China (1993-95) to prevent neural tube defects with 400 μg/day folic acid supplementation and 1194 participants in a population based randomized trial (2003-05) to evaluate the effect of folic acid supplementation on blood folate concentration among Chinese women of reproductive age. INTERVENTION: Folic acid supplementation (400 μg/day). MAIN OUTCOME MEASURES: Estimated RBC folate concentration at time of neural tube closure (day 28 of gestation) and risk of neural tube defects. RESULTS: Risk of neural tube defects was high at the lowest estimated RBC folate concentrations (for example, 25.4 (95% uncertainty interval 20.8 to 31.2) neural tube defects per 10,000 births at 500 nmol/L) and decreased as estimated RBC folate concentration increased. Risk of neural tube defects was substantially attenuated at estimated RBC folate concentrations above about 1000 nmol/L (for example, 6 neural tube defects per 10,000 births at 1180 (1050 to 1340) nmol/L). The modeled dose-response relation was consistent with the existing literature. In addition, neural tube defect risk estimates developed using the proposed model and population level RBC information were consistent with the prevalence of neural tube defects in the US population before and after food fortification with folic acid. CONCLUSIONS: A threshold for "optimal" population RBC folate concentration for the prevention of neural tube defects could be defined (for example, approximately 1000 nmol/L). Population based RBC folate concentrations, as a biomarker for risk of neural tube defects, can be used to facilitate evaluation of prevention programs as well as to identify subpopulations at elevated risk for a neural tube defect affected pregnancy due to folate insufficiency.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study
(1991) · The Lancet · doi:10.1016/0140-6736(91)90133-a · Cited by 3,472
Dietary supplement use and folate status during pregnancy in the United States
Branum, A. M., Bailey, R., & Singer, B. J. (2013) · The Journal of Nutrition · doi:10.3945/jn.112.169987 · Cited by 152
Cited by
Biomarkers of Nutrition for Development—Folate Review
Bailey, L. B., Stover, P. J., McNulty, H., Fenech, M. F., Gregory, J. F., Mills, J. L., Pfeiffer, C. M., Fazili, Z., Zhang, M., Ueland, P. M., et al. (2015) · The Journal of Nutrition · doi:10.3945/jn.114.206599 · Cited by 1,136
Self-citationNeural Tube Defects: A Review of Global Prevalence, Causes, and Primary Prevention
Kancherla, V. (2023) · Child's Nervous System · doi:10.1007/s00381-023-05910-7 · Cited by 145
Wang, G., Hu, F. B., Mistry, K. B., Zhang, C., Ren, F., Huo, Y., Paige, D., Bartell, T., Hong, X., Caruso, D., et al. (2016) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2016.0845 · Cited by 86
Catena, A., Muñoz-Machicao, J. A., Torres-Espínola, F. J., Martínez-Zaldívar, C., Diaz-Piedra, C., Gil, A., Haile, G., Györei, E., Molloy, A. M., Decsi, T., et al. (2016) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.109108 · Cited by 46
Self-citation
Metadata
- Authors
- Crider, K. S., Devine, O., Hao, L., Dowling, N. F., Li, S., Molloy, A. M., Li, Z., Zhu, J., & Berry, R. J.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2014-07-29
- Volume
- 349
- Issue
- jul29 3
- Pages
- g4554-g4554
- ISSN
- 1756-1833 (ISSN-L)
- OpenAlex
- W2075921398
- Cited by
- 206
- References
- 2
- FWCI
- 15.71
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.